Immediate Impact
62 standout
Citing Papers
Present and future of cancer nano-immunotherapy: opportunities, obstacles and challenges
2025 Standout
Diabetes-Driven Atherosclerosis: Updated Mechanistic Insights and Novel Therapeutic Strategies
2025 Standout
Works of Thomas Mehrling being referenced
Abstract CT023: Dose escalation of tinostamustine in patients with advanced solid tumors
2019
The Alkylating-HDAC Inhibition Fusion Principle: Taking Chemotherapy to the Next Level with the First in Class Molecule EDO-S101
2015
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Thomas Mehrling | 130 | 72 | 79 | 22 | 252 | |
| Katharina Prochazka | 82 | 38 | 79 | 17 | 234 | |
| Sichu Liu | 57 | 58 | 70 | 25 | 231 | |
| Thomas Mika | 75 | 29 | 135 | 27 | 268 | |
| Pedro Sánchez‐Godoy | 96 | 46 | 64 | 18 | 216 | |
| Eva Lumbreras | 144 | 62 | 58 | 23 | 297 | |
| Jan Konrad Siwicki | 141 | 30 | 67 | 25 | 251 | |
| Anna Petráčková | 90 | 95 | 71 | 18 | 284 | |
| Edwin Kingsley | 101 | 73 | 151 | 24 | 294 | |
| Federica Melle | 86 | 43 | 125 | 18 | 269 | |
| Ana Batlle | 50 | 54 | 112 | 15 | 242 |
All Works
Login with ORCID to disown or claim papers
Loading papers...